Samuel T. Pellom

778 total citations
22 papers, 620 citations indexed

About

Samuel T. Pellom is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Samuel T. Pellom has authored 22 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Samuel T. Pellom's work include Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Samuel T. Pellom is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (4 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Samuel T. Pellom collaborates with scholars based in United States and Japan. Samuel T. Pellom's co-authors include Jeffrey Schlom, Caroline Jochéms, Claire Smalley, Anil Shanker, Menaka C. Thounaojam, Y. Maurice Morillon, Amosy E. M’Koma, Li Wang, Jeremy N. Myers and Thomas J. Sayers and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Samuel T. Pellom

22 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Samuel T. Pellom United States 16 284 242 214 123 83 22 620
Kirti V. Sawant United States 15 406 1.4× 224 0.9× 222 1.0× 100 0.8× 26 0.3× 20 836
Alex Abel United States 7 632 2.2× 285 1.2× 262 1.2× 77 0.6× 62 0.7× 12 978
Kohei Tada Japan 15 158 0.6× 242 1.0× 220 1.0× 66 0.5× 51 0.6× 33 594
Antao Xu China 8 210 0.7× 246 1.0× 231 1.1× 132 1.1× 59 0.7× 20 657
Joseph R. Piccotti United States 13 456 1.6× 135 0.6× 211 1.0× 78 0.6× 83 1.0× 27 816
Saikiran K. Sedimbi Sweden 13 531 1.9× 136 0.6× 207 1.0× 68 0.6× 91 1.1× 29 747
Arezoo Hosseini Iran 16 393 1.4× 258 1.1× 239 1.1× 56 0.5× 65 0.8× 28 935
Alexandra Adamczyk Germany 12 414 1.5× 179 0.7× 175 0.8× 55 0.4× 66 0.8× 16 676
Ariel Ramírez-Labrada Spain 15 296 1.0× 293 1.2× 325 1.5× 107 0.9× 18 0.2× 28 740
Curtis J. Henry United States 16 433 1.5× 213 0.9× 272 1.3× 51 0.4× 38 0.5× 49 887

Countries citing papers authored by Samuel T. Pellom

Since Specialization
Citations

This map shows the geographic impact of Samuel T. Pellom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel T. Pellom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel T. Pellom more than expected).

Fields of papers citing papers by Samuel T. Pellom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel T. Pellom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel T. Pellom. The network helps show where Samuel T. Pellom may publish in the future.

Co-authorship network of co-authors of Samuel T. Pellom

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel T. Pellom. A scholar is included among the top collaborators of Samuel T. Pellom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel T. Pellom. Samuel T. Pellom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pellom, Samuel T., Claire Smalley, Y. Maurice Morillon, et al.. (2021). Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009. JCI Insight. 6(7). 20 indexed citations
2.
Pellom, Samuel T., et al.. (2020). Examining breast cancer disparities in African Americans with suggestions for policy. Cancer Causes & Control. 31(9). 795–800. 10 indexed citations
3.
Morillon, Y. Maurice, Claire Smalley, Samuel T. Pellom, et al.. (2020). The Use of a Humanized NSG-β2m−/− Model for Investigation of Immune and Anti-tumor Effects Mediated by the Bifunctional Immunotherapeutic Bintrafusp Alfa. Frontiers in Oncology. 10. 549–549. 18 indexed citations
4.
Smalley, Claire, Samuel T. Pellom, Y. Maurice Morillon, Jeffrey Schlom, & Caroline Jochéms. (2020). Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine. Journal for ImmunoTherapy of Cancer. 8(1). e000612–e000612. 59 indexed citations
5.
Pellom, Samuel T., Claire Smalley, Y. Maurice Morillon, et al.. (2020). Anti-tumor efficacy and immune responses induced by a novel therapeutic HPV-specific gorilla adenovirus off-the-shelf immunotherapeutic (PRGN-2009). The Journal of Immunology. 204(1_Supplement). 91.6–91.6. 3 indexed citations
6.
Smalley, Claire, et al.. (2020). <p>Therapeutic Vaccines for HPV-Associated Malignancies</p>. ImmunoTargets and Therapy. Volume 9. 167–200. 83 indexed citations
7.
Jochéms, Caroline, Sarah R. Tritsch, Karin M. Knudson, et al.. (2018). The multi-functionality of N-809, a novel fusion protein encompassing anti-PD-L1 and the IL-15 superagonist fusion complex. OncoImmunology. 8(2). e1532764–e1532764. 34 indexed citations
8.
Jochéms, Caroline, Sarah R. Tritsch, Samuel T. Pellom, et al.. (2017). Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824). Oncotarget. 8(43). 75217–75231. 43 indexed citations
9.
Pellom, Samuel T., Aramandla Ramesh, Tongwen Zhang, et al.. (2016). Validation of research trajectory 1 of an Exposome framework: Exposure to benzo(a)pyrene confers enhanced susceptibility to bacterial infection. Environmental Research. 146. 173–184. 14 indexed citations
10.
11.
Pellom, Samuel T., Menaka C. Thounaojam, Roman V. Uzhachenko, et al.. (2016). Bortezomib augments lymphocyte stimulatory cytokine signaling in the tumor microenvironment to sustain CD8+T cell antitumor function. Oncotarget. 8(5). 8604–8621. 17 indexed citations
12.
Pellom, Samuel T., et al.. (2016). Tributyltin exposure alters cytokine levels in mouse serum. Journal of Immunotoxicology. 13(6). 870–878. 7 indexed citations
13.
Shanker, Anil, Samuel T. Pellom, Menaka C. Thounaojam, et al.. (2015). Bortezomib Improves Adoptive T-cell Therapy by Sensitizing Cancer Cells to FasL Cytotoxicity. Cancer Research. 75(24). 5260–5272. 23 indexed citations
14.
Thounaojam, Menaka C., Samuel T. Pellom, Roman V. Uzhachenko, et al.. (2015). Bortezomib enhances expression of effector molecules in anti-tumor CD8+ T lymphocytes by promoting Notch-nuclear factor-κB crosstalk. Oncotarget. 6(32). 32439–32455. 30 indexed citations
15.
Pellom, Samuel T., et al.. (2015). Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.. PubMed. 6(1). 1–16. 20 indexed citations
16.
Myers, Jeremy N., et al.. (2015). Characterization of Serum Cytokine Profile in Predominantly Colonic Inflammatory Bowel Disease to Delineate Ulcerative and Crohn's Colitides. SHILAP Revista de lepidopterología. 8. CGast.S20612–CGast.S20612. 77 indexed citations
17.
18.
Pellom, Samuel T., Ryan D. Michalek, Katie E. Crump, et al.. (2013). Increased Cell Surface Free Thiols Identify Effector CD8+ T Cells Undergoing T Cell Receptor Stimulation. PLoS ONE. 8(11). e81134–e81134. 15 indexed citations
19.
Pellom, Samuel T.. (2012). Development of Proteasome Inhibitors as Therapeutic Drugs. Journal of Clinical & Cellular Immunology. 1(S5). 5–5. 35 indexed citations
20.
Michalek, Ryan D., Samuel T. Pellom, Beth C. Holbrook, & Jason M. Grayson. (2008). The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth. Virology. 379(2). 205–212. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kirti V. Sawant Breakdown of academic impact, for papers by Alex Abel Breakdown of academic impact, for papers by Kohei Tada Breakdown of academic impact, for papers by Antao Xu Breakdown of academic impact, for papers by Joseph R. Piccotti Breakdown of academic impact, for papers by Saikiran K. Sedimbi Breakdown of academic impact, for papers by Arezoo Hosseini Breakdown of academic impact, for papers by Alexandra Adamczyk Breakdown of academic impact, for papers by Ariel Ramírez-Labrada Breakdown of academic impact, for papers by Curtis J. Henry
Rankless by CCL
2026